2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11947919 2024-05-01 2025-04-30 11947919 2025-04-30 11947919 2024-04-30 11947919 2023-05-01 2024-04-30 11947919 2024-04-30 11947919 2023-04-30 11947919 bus:Director1 2024-05-01 2025-04-30 11947919 core:WithinOneYear 2025-04-30 11947919 core:WithinOneYear 2024-04-30 11947919 bus:Micro-entities 2024-05-01 2025-04-30 11947919 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 11947919 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 11947919 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 11947919 bus:FullAccounts 2024-05-01 2025-04-30
COMPANY REGISTRATION NUMBER: 11947919
CHARLOTTE REES ONCOLOGY LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
30 April 2025
CHARLOTTE REES ONCOLOGY LIMITED
BALANCE SHEET
30 April 2025
2025
2024
£
£
Fixed assets
743
945
----
----
Current assets
24,891
27,369
Prepayments and accrued income
2,820
-------
-------
27,711
27,369
Creditors: amounts falling due within one year
19,311
16,056
-------
-------
Net current assets
8,400
11,313
------
-------
Total assets less current liabilities
9,143
12,258
Accruals and deferred income
2,000
2,000
------
-------
7,143
10,258
------
-------
Capital and reserves
7,143
10,258
------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 10 October 2025 , and are signed on behalf of the board by:
Dr C Rees
Director
Company registration number: 11947919
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Crossways Business Centre, Bicester Road, Kingswood, Aylesbury, HP18 0RA, Bucks.